We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

EKF Diagnostics

Manufactures analysers for the measurement of glucose, lactate, hemoglobin, hematocrit and HbA1c for GP surgeries, ph... read more Featured Products: More products

Download Mobile App





EKF Diagnostics Highlights Assay for Diabetes Patient Monitoring

By LabMedica International staff writers
Posted on 06 Aug 2019
Global in vitro diagnostics company EKF Diagnostics (Penarth, Cardiff, UK) showcased its liquid, enzymatic test for glycated albumin (GA) at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo held on August 4-8, at the Anaheim Convention Center in California, USA. More...
The GA test, which was recently FDA cleared for sales in the U.S, is used for intermediate term monitoring of glycemic control in diabetes patients. EKF is the exclusive distributor of the Lucica Glycated Albumin-L test manufactured by Asahi-Kasei Pharma Corporation of Japan.

The Lucica Glycated Albumin-L test is intended for use for the quantitative measurement of GA in human serum on compatible clinical chemistry analyzers with open channel capability. It specifically measures both glycated albumin (enzymatic) and total albumin (BCP) in separate reactions. Results are expressed as a ratio (%) of glycated albumin to total albumin, thus minimizing differences in protein concentrations between patients. Visitors to EKF Diagnostics’ booth also had the opportunity to meet the inventor of this enzymatic method for GA, Takuji Kohzuma Ph.D, Chief Researcher, Diagnostics and Clinical Development for Asahi Kasei Pharma Corporation. For the development of this methodology, Dr. Kohzuma was awarded the ‘Prize of Technology’ by the Japanese Society of Clinical Chemistry in 2005. The Lucica GA has been one of the most widely used and published enzymatic GA methods in the world.

At AACC 2019, EKF Diagnostics also showcased some of its other clinical chemistry focused products, including another key assay in its portfolio, the Beta-Hydroxybutyrate LiquiColor Assay (B-HB). The LiquiColor B-HB test features liquid, ‘ready to use’ reagents and is intended for the quantitative measurement of B-HB with serum or plasma on compatible clinical chemistry analyzers with open channel capability.

EKF Diagnostics’ central laboratory and point-of-care (POC) analyzers were also on display at this year’s AACC, including the Altair 240, a fully-automated bench-top clinical chemistry analyzer, and the HemoPoint H2 POC analyzer that is designed to rapidly provide quantitative, lab quality hemoglobin and hematocrit results from a single drop of blood. At AACC 2019, EKF Diagnostics exhibited Hemo Control, a point-of-care hemoglobin analyzer designed to provide quantitative, lab quality hemoglobin results from 25 seconds, and DiaSpect Tm, the world’s fastest hemoglobin analyzer that delivers laboratory quality results in just about one second of the microcuvette being placed into the analyzer. The company also showcased Quo-Test, a fully automated desktop POC analyzer designed for easy and reliable HbA1c measurement, and Creamatocrit Plus, the first and only system dedicated to providing a fast, accurate creamatocrit measure in mother’s milk.


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.